市场调查报告书

皮肤癌治疗领域 - 交易分析

Skin Cancers Therapeutics Area - Deals Analytics H2 2020 Report

出版商 GervanoRA Data Services LLP 商品编码 968651
出版日期 内容资讯 英文 63 Pages
订单完成后即时交付
价格
皮肤癌治疗领域 - 交易分析 Skin Cancers Therapeutics Area - Deals Analytics H2 2020 Report
出版日期: 2020年11月04日内容资讯: 英文 63 Pages
简介

本报告提供皮肤癌症治疗领域调查分析,合作伙伴形势的整体竞争相关的系统性资讯。

调查内容:

  • 交易类型为基础的分析
  • 交易为基础的分析:各金额
  • 交易以地区为基础的分析
  • 交易厂商为基础的分析
  • 每1年的分析
  • 交易频率为基础的分析
  • 运作中的交易企业为基础的分析
  • 联盟交易,金融交易,授权交易,著重了M&A交易的分析

目录

第1章 皮肤癌症概要

  • 简介
  • 治疗流程、指南
  • 流行病学研究
    • 全球趋势、历史的趋势

第2章 皮肤癌症的市场动态,竞争领域

  • 交易(合并/收购/联盟)
    • 交易分析:各交易类型
    • 交易分析:各年度频率
    • 交易分析:运作中的各企业
目录

GervanoRA's 'Skin Cancers Therapeutics Areas - Deals Analytics H2 2020 Report' has analyzed and provided an understanding of the overall competition in partnering landscape in the disease area that has occurred from the year 2010.

GervanoRA has analyzed more than 681 drug candidates in the current development pipeline. Hence, a number of emerging and clinical-stage companies are embarking with collaborations or partnerships with different pharma companies to aid in the development process of their respective drug candidates. In the light of rocketing competition, not only companies, but also universities, institutes and research centers are getting actively involved in the advancements of new medicines for the treatment of the disease.

The report through its meticulous analysis on global therapeutic landscape of Skin Cancers Therapeutics Areas deals assists companies in taking future partnering decisions based on competitor's R&D activities; current trends in partnering landscape in order to avoid or mitigate competitive market risks.

For a proper understanding, GervanoRA has segmented the report into sections based on:

  • Analytics Based on Deal Type,
  • Analytics Based on Deal by Value,
  • Analytics Based on Deal Geography
  • Analytics Based on Deal Maker
  • Year-by-Year Analytics
  • Analytics Based on Deal Frequency
  • Analytics Based on Deal Active Player
  • Analytics Based on More Emphasis on Collaboration Deals, Financing Deals, Licensing Deals, Merger & Acquisition Deals.

The report also includes Brief over view on Skin Cancers and Skin Cancer Types, and Epidemiological Studies.

TABLE OF CONTENTS

CHAPTER 01: SKIN CANCERS OVERVIEW 4

  • 1.1. INTRODUCTION 4
  • 1.2. TREATMENT ALGORITHM AND GUIDELINES 7
  • 1.3. EPIDEMIOLOGY STUDIES 14
    • 1.3.1. GLOBAL AND HISTORICAL TRENDS 15
      • 1.3.1.1. UNITED STATES 17
      • 1.3.1.2. AUSTRALIA 18
      • 1.3.1.3. EUROPE 19

CHAPTER 02: MARKET DYNAMICS OF SKIN CANCERS COMPETITIVE SPACE 21

  • 2.1. DEALS (MERGERS/ ACQUISITIONS/ COLLABORATIONS) 21
    • 2.1.1 DEALS ANALYTICS BY DEAL TYPE 21
      • 2.1.1.1. COLLABORATION DEALS 22
      • 2.1.1.2. FINANCING DEALS 37
      • 2.1.1.3. LICENSING DEALS 43
      • 2.1.1.4. MERGER AND ACQUISITION DEALS 50
    • 2.1.2 DEALS ANALYTICS BY ANNUAL FREQUENCY 57
    • 2.1.3 DEALS ANALYTICS BY ACTIVEPLAYER 58